Tvardi Therapeutics, Inc. Gains 61.29%
Wed, Jul 08, 2026 at 07:49 PM
Tvardi Therapeutics, Inc. (TVRD:NASDAQ) jumped higher at $5, representing a gain of 61.3%. On Wed, Jul 08, 2026, TVRD:NASDAQ touched a New 2-Week High of $5. The stock got featured on our News Catalysts scanner on Tue, Jul 07, 2026 at 09:16 AM in the 'BIOTECH' category. From Wed, Jun 24, 2026, the stock recorded 66.67% Up Days and 70.00% Green Days
About Tvardi Therapeutics, Inc. (TVRD:NASDAQ)
Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.
Top 10 Gainers:
- Catheter Precision, Inc. (VTAK:NYSEMKT), 92.23%
- Nuvve Holding Corp. (NVVE:NASDAQ), 63.58%
- Tvardi Therapeutics, Inc. (TVRD:NASDAQ), 61.29%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 45.93%
- iOThree Limited (IOTR:NASDAQ), 39.92%
- Edible Garden AG Incorporated (EDBL:NASDAQ), 32.27%
- Sky Quarry Inc. (SKYQ:NASDAQ), 27.33%
- Canaan Inc. (CAN:NASDAQ), 25.92%
- Penguin Solutions, Inc. (PENG:NASDAQ), 25.13%
- Zenta Group Company Limited (ZTG:NASDAQ), 25%